RE

Regeneron Pharmaceuticals IncNASDAQ REGN Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

124.33

Mega

Exchange

XNAS - Nasdaq

View Full Company Analysis

Free cash flow to equity FCFE

0.14 B

Last period FCFE ,USD

53%

FCFE has increased in 5 years


What is FCFE ?

Free cash flow is the amount of cash a company has after all operating expenses, interest and taxes, and capital expenditures have been paid.

What is FCFE ?

Free cash flow is the amount of cash a company has after all operating expenses, interest and taxes, and capital expenditures have been paid.

What is FCFE of Regeneron ?

Regeneron`s FCFE for the period ended 2024-06-30 is 0.14 B USD

View Full Company Analysis